Table 2.
Treatment | Mounts | Mount Latency (secs.) |
Intromissions | Introm. Latency (secs) |
Ejaculations | Ejaculation Latency (secs) |
---|---|---|---|---|---|---|
Control | 10.5 ± 2.10 | 554.8 ± 199.6 | 18.0 ± 4.30 | 552.3 ± 170 | 1.5 ± 0.31 | 875.6 ± 167.5 |
RFRP-3 (500 ng) |
10.6 ± 2.26 | 649.2 ± 187.4 | 18.5 ± 3.72 | 288 ± 61.31 | 1.6 ± 0.28 | 973.8 ± 186.0 |
RFRP-3 (100 ng) |
9.8 ± 3.1 | 721 ± 98.3 | 17.1 ± 2.88 | 571 ± 83.11 | 1.3 ± 0.7 | 1011.1 ± 211.3 |
No significant differences were observed between treatment groups (p > 0.05).
Data presented as means ± SEM.